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Background: Deep brain stimulation (DBS) in the subthalamic nucleus (STN) significantly reduces symptoms of
Parkinson’s disease (PD) such as bradykinesia, tremor and rigidity. It also reduces the need for anti-PD medication,
and thereby potential side-effects of L-Dopa. Although DBS in the STN is a highly effective therapeutic intervention
in PD, its mechanism and effects on oculomotor eye movement control and particularly smooth pursuit eye
movements have to date rarely been investigated. Furthermore, previous reports provide conflicting information.
The aim was to investigate how DBS in STN affected oculomotor performance in persons with PD using novel
analysis techniques.
Methods: Twenty-five patients were eligible (22 males, 3 females) according to the clinical inclusion criteria:
idiopathic PD responsive to L-Dopa and having had bilateral STN stimulation for at least one year to ensure stable
DBS treatment. Fifteen patients were excluded due to the strict inclusion criteria applied to avoid interacting and
confounding factors when determining the effects of DBS applied alone without PD medication. One patient
declined participation. Nine PD patients (median age 63, range 59–69 years) were assessed after having their PD
medications withdrawn overnight. They were examined with DBS ON and OFF, with the ON/OFF order individually
randomized.
Results: DBS ON increased smooth pursuit velocity accuracy (p < 0.001) and smooth pursuit gain (p = 0.005),
especially for faster smooth pursuits (p = 0.034). DBS ON generally increased saccade amplitude accuracy (p = 0.007)
and tended to increase peak saccade velocity also (p = 0.087), specifically both saccade velocity and amplitude
accuracy for the 20 and 40 degree saccades (p < 0.05). Smooth pursuit latency tended to be longer (p = 0.090)
approaching normal with DBS ON. Saccade latency was unaffected.
Conclusions: STN stimulation from DBS alone significantly improved both smooth pursuit and saccade
performance in patients with PD. The STN stimulation enhancement found for oculomotor performance suggests
clear positive implications for patients’ ability to perform tasks that rely on visual motor control and visual feedback.
The new oculomotor analysis methods provide a sensitive vehicle to detect subtle pathological modifications from
PD and the functional enhancements produced by STN stimulation from DBS alone.
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Parkinson’s disease (PD) is the second-most common neu-
rodegenerative disorder after Alzheimer’s disease and in-
flicts an increasing social and economic burden on society
as population ages [1]. The prevalence of PD in industrial-
ized countries is estimated to be about 0.3% for the entire
population, 1% in people over 60 years of age [2] rising to
4% in people over 80 years of age [3].
In PD, an insufficient formation and action of dopamine
in the substantia nigra pars compacta causes defective
transmission of impulses from the Basal ganglia (BG) [4,5].
The BG influences many cortical functions through several
parallel Basal ganglia-thalamo-cortical loops, e.g. limbic,
motor and oculomotor loops [6]. For motor and oculo-
motor circuits, the BG is believed to play a role in selecting
which initiating drives are allowed to be expressed as re-
sponses through the control of the thalamo-cortical and
brainstem motor networks [7]. One of the main manifesta-
tions of PD is therefore motor dysfunction, and this forms
part of its clinical diagnosis.
A diagnosis of PD is based on the presence of at least
two of the following symptoms: resting tremor, brady-
kinesia, rigidity or postural imbalance [5]. The diagnosis is
confirmed by a positive response to levodopa (L-Dopa) [1].
However, the degree of the motor symptoms might not be
strictly related to the degree of disease progression [8,9].
Only some patients may present postural tremor; patients
with striatal deformities tend to be younger and postural
instability due to the loss of postural reflexes generally oc-
curs in the later stages of PD and usually after the onset of
other clinical features [5,10]. Oculomotor performance
such as saccadic and smooth pursuit eye movements is
also affected by PD [11-15], and this could potentially
offer an additional opportunity for evaluating the disease
severity or progression.
Ocular movements, including saccadic and smooth
pursuit, have increasingly been used to detect subtle
pathological modifications caused by neurological defi-
cits or lesions [14,16,17]. Saccadic eye movements are
high-velocity, ballistic changes in eye position that bring
an object of interest onto the fovea centralis retinae,
whereas smooth pursuit eye movements are tracking
movements ensuring that the image of a moving object
is maintained on the fovea [18]. Oculomotor responses
are vital for safe movement control and orientation and
therefore for many daily activities [19]. Several areas are
involved in the generation of oculomotor responses such
as the frontal eye field, the supplementary eye field, the
dorsolateral prefrontal cortex and the superior colliculus
[20,21]. These areas all receive input integrated through
the BG and are regulated by inhibitory mechanisms [5].
Deep brain stimulation (DBS) in the subthalamic nu-
cleus (STN) significantly reduces the PD symptoms of
bradykinesia, tremor, rigidity and the need for anti-PDmedication, which further reduces the motor complica-
tions from dopamine therapy [3]. Previous studies have
shown that DBS in the STN can improve saccadic
performance and orienting gaze movements [22-28]. To
the best of our knowledge, only one previous study, by
Pinkardt and colleagues has evaluated the specific effects
of DBS on smooth pursuit [29]. This recent study assessed
the effects of DBS in the STN while participants remained
on anti-PD medication and showed no difference between
DBS ON and DBS OFF. We intend to assess oculomotor
control with DBS in the STN following withdrawal of
anti-PD medication from the previous night to illustrate
the effects without medication and to compare saccade
and smooth pursuits on the same patients. Hence, the ef-
fect of DBS in the STN on smooth pursuit eye movements
is largely unknown, whereas the described effects of PD
medication on smooth pursuit performance differ between
reports [11,14,30,31].
The aim of the present study was to evaluate the effect
of STN stimulation alone (i.e. without anti-PD medication)
on oculomotor performance in persons with PD using both
traditional quantitative methods and two newer analysis
methods specifically looking at smooth pursuit velocity
accuracy and the ratio between saccade velocity and sac-
cade amplitude, the latter commonly called main sequence.
These newer methods have shown better sensitivity in
detecting subtle pathological dysfunctions compared to
conventional methods [32,33]. Therefore, these methods
might further elucidate how PD influences smooth pursuit
and saccade eye movements and the effectiveness of STN
stimulation to enhance oculomotor functions in patients
with PD. A second aim was to compare the objective re-
cordings of ocular movements and subjective scores from
the Unified Parkinson’s Disease Rating Scale (UPDRS) part
III, i.e., motor examination.
Materials and methods
Patients
Twenty-five patients were eligible (22 men, three women)
according to the inclusion criteria: idiopathic PD respon-
sive to L-Dopa, between 50–70 years old and having had
bilateral STN stimulation for at least one year to ensure
stable DBS treatment. Fifteen patients were excluded due
to the following exclusion criteria: concomitant diseases
interfering with testing, an inability to cooperate or an in-
ability to stand for two minutes without support since
standing assessment is a part of the UPDRS part III. One
patient declined participation.
Nine patients with PD participated in the study (median
age 63, range 59–69 years). Descriptive information (e.g. L-
dopa equivalents and DBS parameter settings) is provided
in Table 1. The neurosurgical procedure has been described
elsewhere [34]. All patients were recruited from the Depart-
ment of Neurosurgery, Skåne University Hospital.
Table 1 Patients’ characteristics and scores of the UPDRS part III
Sex 8 men, 1 woman
Age (years) at surgery, mean (SD) 63.2 (3.9)
PD-duration (years), mean (SD) 16.3 (3.6)
L-dopa equivalents (mg/day), mean (SD) 481.5 (242.1)
Months since DBS-surgery, mean (SD) 42.0 (20.1)
DBS parameter settings, mean (SD), Amplitude (V), pulse width (μs), Frequency (Hz) Right: 3.4 (0.54) V, 66.7 (13.2)μs, 138.3 (40.2) Hz
Left: 3.4 (0.62) V, 66.7 (13.2)μs, 138.3 (40.2) Hz
Location of contacts with negative polarity, in relation to the midpoint of the
intercommissural line (IC), mean (SD)
Right: 11.3 (0.91) mm lateral, 3.5 (0.33) mm posterior, 2.4
(1.4) mm inferior.
Left: 11.3 (0.95) mm lateral, 3.9 (0.70) mm posterior, 2.8
(1.0) mm inferior.
IC = 24.8 (0.59) mm
UPDRS part III scores, without anti-PD medication
- DBS turned OFF, median (q1-q3) 42.5 (38.3-56.5)
- DBS turned ON, median (q1-q3) 22.0 (17.5-25.3)
Levodopa equivalents are calculated according to Østergaard et al., and Calne.
UPDRS part III: Unified Parkinson’s Disease Rating Scale, motor examination. Higher scores denote more severe motor symptoms. The maximum total score on the
UPDRS part III is 108 points, and higher scores reflect more severe motor symptoms.
Without medication: Overnight withdrawal of all anti-Parkinsonian medication for 10–12 hours. All individuals were on L-dopa, and seven out of the nine
participants were also on dopamine agonists (ranging from 20-50% of LED). When tested, all participants experienced off symptoms.
Of note, the assessments of severity of PD using UPDRS scores were done at the same occasion as the assessments of oculomotor functions.
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formed six months prior to the study in all nine patients,
and if needed the DBS and/or medication was adjusted to
optimize treatment. The experiments were performed in
accordance with the most recent Helsinki declaration. The
Regional Ethical Board approved the study and all patients
gave written informed consent.
Procedure & assessments
To investigate the effects of STN stimulation alone, all
anti-PD medications were withdrawn overnight (from 10
pm) while all participants were kept as in-patients. The
following morning, an independent person programmed
the DBS to either ON or OFF. The order (i.e., DBS ON/
OFF) was randomized to avoid any systematic differ-
ences and bias. The assessments were performed thirty
minutes after programming the DBS. Short breaks were
allowed between the individual tests if needed.
UPDRS part III (motor examination) was used to de-
scribe and evaluate motor symptoms [35] (Table 1). Each
patient was always assessed by the same examiner i.e., a
PD nurse or a neurologist. The UPDRS investigator was
blind to the randomization order. The UPDRS assessment
was followed by the assessments of oculomotor functions,
where one test session took at its most 30 minutes. The
DBS was then reprogrammed by an independent person.
During the following 30 minutes, participants had a break
and a light meal (fruit, sandwich and mineral water). The
test session was repeated in the other DBS state and the
UPDRS and oculomotor assessments performed in the
same order.Equipment
The visual target used in the oculomotor tests was a circu-
lar red dot with a diameter of 3mm projected onto a dark
canvas screen (2m height vs. 3m width) about 1.3m in
front of the subjects. The visual target was produced by a
diode laser contained within a mobile over-head console,
allowing optimal vertical positioning of the visual target
for each individual. The eye movements were recorded by
electronystagmography (ENG) by means of a bipolar re-
cording technique. Two Ag/AgCl ENG-electrodes were
placed about 1cm from the outer canthi of the eyes to
measure horizontal eye movements. Two other electrodes
were fixed above and below the left eye to measure the
vertical eye movements and eye blinks. Finally, one
ground electrode was attached on the mid-forehead. Be-
fore each test, a calibration procedure was performed to
ensure that the electrical ENG signals within the range
of ±30 degree amplitude in horizontal direction correctly
corresponded to right and left eye movements, with an
error less than 1 degree at the 30 degree amplitude. In the
vertical direction, the calibration amplitude was set with
reference to eye blinking. A customized program Vestcon™
controlled the visual target projection, calibration and
sampled the ENG data at 200 Hz. The computer program
also analyzed the ENG data.
Smooth pursuit eye movement recordings
All participants were tested in a completely dark room,
seated in an inclined chair directly in front of a black can-
vas screen. They were instructed to fixate on the target
and follow its movement as accurately as possible without
Nilsson et al. Journal of NeuroEngineering and Rehabilitation 2013, 10:33 Page 4 of 12
http://www.jneuroengrehab.com/content/10/1/33turning their head or moving their eyes before the target
movement. A custom-made headrest prevented inappro-
priate head movements. Fixed smooth pursuit tests se-
quences were used in this study to ensure that all test
conditions and the test sequences themselves were identi-
cal and equally difficult to perform with DBS OFF and
DBS ON. The smooth pursuit target moved horizontally
with a constant velocity from side to side, with a range
of ±30° of the visual field, i.e. a distance of 60° between (+)
30° to the right and (−) 30° to the left. The smooth pursuit
test was performed in a set-order of different velocities:
10, 20, 30, 40, 40, 30, 20, 10°/s. At each velocity, the
smooth pursuit eye movements were tested 4 times, i.e.
two times per direction (right to left and left to right).
When the visual target reached the maximum amplitude,
either to the right or left, the position was maintained for
1 second before the next movement commenced in the
opposite direction. In total, 8 smooth pursuits for each
smooth pursuit target velocity investigated were analyzed,
giving a total of 32 smooth pursuits analyzed for each
DBS state and a sum of 64 smooth pursuits analyzed for
each PD participant.
Saccadic eye movement recordings
The conditions and calibration before the saccade tests
were identical to the smooth pursuit assessments and in-
structions were the same. Fixed saccade test sequences
were used to ensure that all test conditions were identi-
cal and the tests equally difficult to perform with DBS
OFF and DBS ON. The visual target jumped stepwise
horizontally according to a sequence of different ampli-
tudes: ±10, ±20, ±30°, yielding saccades of a total range
of respectively 20, 40 and 60° amplitude. The visual tar-
get remained at each position for 1.5s seconds. The sac-
cades were tested 10 times at each of the amplitudes,
five times for saccades from right to left, and five times
for saccades from left to right. The first and last saccade
in each amplitude block of saccades was removed prior
to analysis. In total, 8 saccades for each target amplitude
investigated were analyzed, giving a total of 24 saccades
analyzed for each DBS state and a sum of 48 saccades
analyzed for each PD participant.
Smooth pursuit data analysis
The smooth pursuit analysis method has been described
in detail elsewhere [32,33]. In brief, the smooth pursuit
latency was defined as the time between start of target
movement until the velocity of the recoded eye move-
ment exceeded 5°/s. The calculated latency was regarded
incorrect and rejected if the latency was shorter than 0.1
seconds or longer than 0.6 seconds. Smooth pursuit gain
was calculated by first identifying and removing time
periods where the measured eye movements were pre-
sumed to be saccades or deemed too slow to represent asmooth pursuit eye movements. Average velocity was cal-
culated for the remaining periods, and the gain value was
obtained by dividing the average eye movement velocity
by the target velocity value. Smooth pursuit velocity accu-
racy was obtained by calculating the percentage of time
during the entire movement range when the eye movement
velocity was within the target velocity boundaries of less
than 20% absolute error from the visual target velocity.Saccadic data analysis
The saccade analysis method has been described in de-
tail elsewhere [32,33]. In brief, prior to the analysis of
the saccadic data, the recorded ENG data was low-pass
filtered at a cut-off frequency of 70 Hz. Thereafter, the
data was deemed to obtain the velocity of the eye move-
ments during each individual target movement. The
recorded saccade latency was defined as the time be-
tween start of target movement until the recorded eye
movement velocity exceeded 80°/s. The calculated la-
tency was regarded incorrect and rejected if the latency
was below 0.1 seconds or above 0.6 seconds. The sac-
cade was also rejected if the duration of the saccade was
shorter than 25 ms.
Peak saccade velocity was calculated by first identify-
ing and removing time periods where the recorded eye
movements were slower than 80°/s and where saccades
were shorter than 25 ms. Thereafter, in the remaining
time periods where saccades were found, the 25 ms
period (e.g., 5 samples) where the saccade velocity was
highest during the saccade was determined and the
average saccade velocity during this 25 ms period was
calculated. If the subject made several saccades to
achieve the target movement, the saccade with the
highest peak saccade velocity and with the largest amp-
litude was selected.
The saccade amplitude was calculated as the distance
moved from a start position where the eye movements
began to exceed 80°/s velocity, until an end position i.e.,
where the velocity had decreased below this velocity.
The saccade accuracy for each target movement was
calculated as a quotient value in percent between the
movement amplitude of the largest eye movement sac-
cade (if several saccades were made), divided by the
total movement amplitude of the visual target reference.
Finally, a value describing the general ratio between
peak saccade velocity and saccade amplitude, commonly
called main sequence [36,37], was calculated. This was
done by first dividing peak saccade velocity by saccade
amplitude for all individual saccade target amplitudes to
give a quotient value for each saccade amplitude. There-
after, the average quotient value for all saccade target
amplitude quotients were calculated, which represents
the general ratio.
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Oculomotor performance was based on statistical analysis
of rightward and leftward smooth pursuit and saccadic
eye movements pooled together since no general differ-
ences were found in pair-wise Wilcoxon comparisons
between values obtained from leftward and rightward di-
rected smooth pursuits and saccades (average p-value =
0.521) [26,32].
The effects of DBS OFF and ON (denoted DBS in the
tables) (1 d.f. : OFF or ON); the effects on smooth pur-
suit velocity (Target Velocity) (3 d.f. : 10°/s, 20°/s, 30°/s
or 40°/s ), and the effects on saccade amplitude (Target
Amplitude) (2 d.f. : 20°, 40° or 60°) and their respective
interactions on the smooth pursuit and saccade parame-
ters were analyzed using a repeated-measures GLM
ANOVA (General Linear Model Analysis of Variance)
test [38]. A repeated-measures GLM ANOVA analysis
uses all available data from the assessments made to
build a statistical model that shows how a parameter is
affected by various factors and interactions between
factors. In this study, the analysis include data from
both DBS OFF and ON assessments and all Target
Velocities/ Target Amplitudes respectively to deter-
mine whether the parameter is influenced by the main
factors (DBS, Target Velocity/Target Amplitude) and
interactions between the main factors (e.g., that DBS ON
enhance more the ability to perform faster smooth pursuits
than slower ones).
The Wilcoxon matched-pairs signed-rank test (Exact
sig. 2-tailed) was used for post-hoc statistical evaluation
of all parameter used, analyzing the differences between
DBS states at the level of individual smooth pursuit vel-
ocities and saccade amplitudes [38].
A correlation analysis was performed using Spearman’s
Rank Correlation test between UPDRS scores and smooth
pursuit and saccade eye movements in DBS ON and OFF
states. Non-parametric statistics were used in the statis-
tical evaluation since not all data sets were normally
distributed before or after logarithmic transformation. In
the statistical analysis, p-values <0.05 were considered sta-
tistically significant [38].
Results
Smooth pursuit eye movements
Repeated-measures GLM analysis of smooth pursuit
parameters
Generally, DBS ON significantly improved smooth
pursuit gains (p = 0.005) and smooth pursuit velocity
accuracies (p < 0.001) compared with DBS OFF (Table 2).
Moreover, smooth pursuit gains were significantly
higher for slower smooth pursuit target velocity move-
ments (p < 0.001). Findings also show that it was easier
for the PD patients to maintain correct smooth pursuit
velocity within the velocity boundaries during fastersmooth pursuit movements (p < 0.001). Furthermore, a
significant interaction between DBS and target velocity
(p = 0.034) for the gain parameter shows that DBS ON
particularly improved the smooth pursuit gains values
for the faster smooth pursuits. There was no significant
interaction between DBS and target velocity for the
smooth pursuit accuracy parameter.
Post hoc analysis of smooth pursuit parameters
Post-hoc analysis of the smooth pursuit parameters at
individual smooth pursuit velocities revealed that
DBS ON significantly increased smooth pursuit gains
with increasing target velocity compared with DBS
OFF (Figure 1A). Smooth pursuit gains were signifi-
cantly higher by 13% for the 20°/s and 40°/s velocities
(p < 0.05) and by 14% for the 30°/s target velocity (p < 0.05)
with DBS ON compared with DBS OFF. Smooth pursuit
gain was not significantly different between DBS ON
and DBS OFF for the 10°/s velocity, though a clear
trend of increased smooth pursuit gain with DBS ON
was observed (p = 0.074).
Smooth pursuit velocity accuracy was significantly in-
creased with DBS ON compared with DBS OFF by 23%
for 10°/s target velocity (p < 0.05); by 29% for 20°/s target
velocity (p < 0.01); by 40% for 30°/s target velocity (p <
0.001) and by 28% for 40°/s target velocity (p < 0.001)
(Figure 1B).
Saccade eye movements
Repeated-measures GLM analysis of saccade parameters
Generally, the saccade amplitude accuracies were signifi-
cantly higher (p = 0.007) with DBS ON compared with
DBS OFF (Table 3). Moreover, a trend suggests that peak
saccade velocity was increased by DBS ON though with-
out reaching significant level (p = 0.087). Additionally,
saccade velocities were significantly higher (p = 0.005)
for larger saccade target amplitudes. Saccade amplitude
accuracies were significantly poorer (p = 0.001) for the
larger saccade target amplitudes. There were no signifi-
cant interaction between DBS and target amplitude on
the saccade parameters analyzed.
Post hoc analysis of saccade parameters
Post-hoc analysis of the saccade parameters at individual
saccade amplitudes revealed that saccade velocity was sig-
nificantly increased with DBS ON compared with DBS
OFF by 14% for the 20 degree saccade target amplitude
(p < 0.05) and by 9% for the 40 degree saccade target amp-
litude (p < 0.05) (Figure 2A). Saccade velocity was not sig-
nificantly different between DBS ON and DBS OFF for
the 60 degree saccade target amplitude.
Saccade amplitude accuracy was significantly increased
with DBS ON compared with DBS OFF by 23% for the 20
degree saccade target amplitude (p < 0.05) and by 26 % for
Table 2 Repeated-measures GLM ANOVA analysis of smooth pursuit parameters
Smooth pursuit parameters Parameter values p-values
Target velocities (°/s) DBS OFF DBS ON DBS Target velocity DBS × Target velocity
Gain 10 0.97 (0.03) 1.00 (0.01) 0.005 (11.0) <0.001 (31.5) 0.034 (5.4)
20 0.86 (0.04) 0.97 (0.01)
30 0.83 (0.05) 0.94 (0.02)
40 0.80 (0.04) 0.90 (0.02)
Velocity Accuracy 10 31.7 (3.1) 39.0 (2.5) <0.001 (18.1) <0.001 (35.0) 0.188 (1.9)
20 37.3 (3.7) 48.2 (3.1)
30 35.8 (3.9) 50.3 (3.5)
40 35.9 (3.3) 46.1 (2.5)
Statistical evaluation of the smooth pursuit parameters (mean and SEM) using the repeated-measures GLM ANOVA method. Bold values indicate found
significance (p < 0.05). The statistical F-values are presented within the parentheses after the p-values.
Figure 1 A Gain values (mean and SEM) for four target
velocities with DBS OFF and ON. A value below 1.00 represent
that the average smooth pursuit velocity was below the target
velocity. B: Smooth pursuit velocity accuracy values (mean and SEM)
with DBS OFF and ON. A value of 100 % represents that the eye
movement velocity were always within the boundaries. (# denotes
P < 0.1; * denotes P < 0.05; ** denotes P < 0.01 and ***
denotes P < 0.001).
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2B). Saccade amplitude accuracy was not significantly di-
fferent between DBS ON and DBS OFF for the 60 degree
saccade target amplitude, though a clear trend of in-
creased saccade amplitude accuracy with DBS ON was
observed (p = 0.065).
The saccade ratio between saccade velocity and saccade
amplitude were on average 19.9 (standard error of mean
(SEM) 0.8) with DBS OFF and 16.1 (SEM 0.7) with DBS
ON (p < 0.001), the decrease in saccade ratio found for
DBS ON was mainly due to increased saccade amplitudes.Smooth pursuit and saccade latencies
Average latency for saccades was 177 ms (SEM 12 ms)
with DBS OFF and 156 ms (SEM 10 ms) with DBS ON.
The saccade latency difference was not statistically sig-
nificant between DBS ON and DBS OFF.
Average latency for smooth pursuits was 171 ms (SEM
14 ms) with DBS OFF and 218 ms (SEM 13 ms) with
DBS ON. The smooth pursuit latency difference was not
statistically significant between DBS ON and DBS OFF
though a trend of increased smooth pursuit latency with
DBS ON was observed (p = 0.090).Relationship between UPDRS scores and oculomotor
parameters
The correlation analyses between UPDRS motor scores
with DBS ON and smooth pursuit parameters with DBS
ON revealed indications of relationships (Table 4A). The
UPDRS scores with DBS ON were significantly corre-
lated to smooth pursuit velocity accuracy at 10°/s target
velocity with DBS ON (p < 0.001), the correlation coeffi-
cient values suggesting that those with higher UPDRS
scores had poorer smooth pursuit velocity accuracy. The
correlations also suggest trends of relationships between
UPDRS score and smooth pursuit gain (p = 0.094) and
smooth pursuit velocity accuracy (p = 0.060) at 20°/s tar-
get velocity.
Table 3 Repeated-measures GLM ANOVA analysis of saccade parameters
Saccade parameters Parameter values p-value
Target amplitudes (°) DBS OFF DBS ON DBS Target amplitude DBS × Target amplitude
Velocity 20 236 (16) 269 (18) 0.087 (3.4) 0.005 (10.8) 0.117 (2.8)
40 263 (20) 288 (15)
60 313 (34) 332 (23)
Amplitude Accuracy 20 53.4 (4.2) 65.8 (5.4) 0.007 (10.2) 0.001 (17.0) 0.575 (0.4)
40 38.9 (4.4) 49.0 (2.8)
60 34.6 (5.2) 52.8 (5.3)
Statistical evaluation of the saccade parameters (mean and SEM) using the repeated-measures GLM ANOVA method. Bold values indicate found significance (p < 0.05),
italic values indicate trends of significance (p < 0.1). F-values are presented within the parentheses after the p-values.
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DBS ON and saccade parameters with DBS ON revealed
several significant relationships (Table 4B). The UPDRS
scores with DBS ON were significantly correlated to the
saccade amplitude accuracy at 20° saccade target amplitudeFigure 2 A Saccade eye movement velocity (mean and SEM) for
three saccade amplitudes with DBS OFF and ON. B: Saccade
amplitude accuracy in percentage (mean and SEM) with DBS OFF
and ON. A value of 100 represents perfect saccade amplitude
accuracy whereas values below 100 represent short saccades
(hypometric) (# denotes P < 0.1; * denotes P < 0.05; ** denotes P <
0.01 and *** denotes P < 0.001).(p < 0.05) and saccade amplitude accuracy at 40° saccade
target amplitude (p < 0.05) with DBS ON, the correlation
coefficient values suggesting that those with higher UPDRS
scores had poorer saccade amplitude accuracy. The
UPDRS scores were significantly correlated to the saccade
latency with DBS ON (p < 0.01). The correlations also sug-
gest trends of relationships between UPDRS scores and the
saccade velocity at 20° saccade target amplitude (p = 0.080)
and saccade velocity at 40° saccade target amplitude (p =
0.055).
There were no significant correlations between UPDRS
scores with DBS OFF and any of the smooth pursuit pa-
rameters or saccade parameters with DBS OFF.
Discussion
Smooth pursuit eye movements and deep brain
stimulation
Although DBS in the STN is a highly effective thera-
peutic intervention for PD, its mechanism and effects on
smooth pursuit eye movements have to date been rarely
investigated [39]. One previous study from Pinkhardt
and colleagues has investigated the effect of STN stimu-
lation on smooth pursuit while the participants received
anti-PD medication and found then no significant effect
of DBS [29]. However, the present study reveals that
when STN stimulation was applied alone after with-
drawal of PD medication for 12 hours, DBS significantly
improved smooth pursuit performance, both in terms of
increasing smooth pursuit velocity gain but also by im-
proving the ability to maintain a steady eye movement
velocity without using supportive saccade disruptions or
velocity deviations. The improvements made with DBS
ON were more detectable at faster target velocities both
in smooth pursuit gain and smooth pursuit velocity
accuracy. Comparing the study by Pinkhardt and col-
leagues to the present study there were large differences,
both methodological (i.e. different test situations) and
between the participants (ours had longer disease dur-
ation, i.e., 16.6 versus 10.5 years). Discrepancies between
study results may also be caused by differences in elec-
trode locations and DBS settings, which are not always
Table 4 Correlation values between UPDRS motor scores and oculomotor parameters
A: Smooth pursuit parameters p-values (correlation coefficient)
Target velocities (°/s) DBS OFF DBS ON
Gain 10 0.305 (−0.256) 0.131 (−0.369)
20 0.135 (−0.366) 0.094 (−0.406)
30 0.168 (−0.339) 0.527 (−0.160)
40 0.243 (−0.310) 0.670 (−0.108)
Velocity Accuracy 10 0.150 (−0.354) <0.001 (−0.759)
20 0.767 (−0.075) 0.060 (−0.452)
30 0.627 (−0.123) 0.532 (−0.158)
40 0.466 ( 0.196) 0.521 (−0.162)
Latency 0.265 (−0.320) 0.828 ( 0.059)
B: Saccade parameters p-values
Target amplitudes (°) DBS OFF DBS ON
Velocity 20 0.705 (−0.099) 0.080 (−0.423)
40 0.313 ( 0.252) 0.055 (−0.460)
60 0.539 ( 0.166) 0.338 (−0.248)
Amplitude Accuracy 20 0.518 (−0.168) 0.048 (−0.473)
40 0.503 ( 0.169) 0.048 (−0.473)
60 0.905 (−0.033) 0.811 (−0.063)
Latency 0.404 ( 0.217) 0.009 (−0.614)
Table 4A Correlation values between UPDRS motor scores and smooth pursuit parameters with DBS ON and DBS OFF. The correlation coefficient values are
presented within the parentheses. Table 4B. Correlation values between UPDRS scores and saccade parameters with DBS ON and DBS OFF. Bold values indicate
found significant correlation (p < 0.05), italic values indicate trends of correlation (p < 0.1). A negative correlation coefficient value suggests that PD subjects with
higher UPDRS scores had poorer performance in the oculomotor parameter analyzed.
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derstanding of how STN stimulation affects oculomotor
performance, it may be beneficiary if forthcoming stu-
dies report both electrode locations and DBS-parameter
settings since these are of importance for the results.
Hence, the recorded effectiveness of applied DBS is
likely related to how strong the DBS stimulation is set to
be and to what proportional degree the PD symptoms
are suppressed by DBS stimulation or anti-PD medica-
tion respectively.
The observed, consistently positive, effects of STN sti-
mulation on smooth pursuit performance contrasts with
the lower coherency in the effects reported for PD medi-
cation. Some have reported that dopaminergic therapy im-
proved smooth pursuit velocity gain [11,14], others have
detected no difference [30], whereas some have even
found that dopaminergic therapy worsened smooth pur-
suit velocity gain [31]. Hence, more research is motivated
to investigate whether STN stimulation can provide a bet-
ter stable improvement of smooth pursuit performance
than PD medication or whether induced performance en-
hancements are associated with other factors such as state
of PD progression.
The relationship between PD and smooth pursuit per-
formance has been a subject of debate. There are a num-
ber of reports of decreased smooth pursuit performancein persons with PD [11,16,40,41]. Although abnormal
smooth pursuit eye movements have been reported in
about 75% of the PD patients [42], previous studies have
been unable to conclude why this is as there appeared to
be no direct ocular pursuit pathways traversing the BG
[13]. However, new findings made by Yoshida and Tanaka
[43] provide important physiological evidence for the
existence of an oculomotor feedback circuit involving the
putamen and globus pallidus, structures that have pre-
viously been associated in neurophysiological studies
primarily with the somatomotor system. Although ana-
tomical studies have previously showed projections from
the thalamic nuclei, which receive input from the globus
pallidus to the smooth pursuit subregion of the frontal eye
field [44,45], the study by Yoshida and Tanaka showed a
relationship between neural activity in the globus pallidus
and the pursuit eye movements. Hence, rather than being
controlled primarily by areas in extrastriate cortex special-
ized for processing visual motion, smooth pursuit eye
movements involve an extended network of cortical areas,
including pursuit-related region in the frontal eye fields
and newly identified routes involving structures previously
associated with the control of saccades, including the basal
ganglia, the superior colliculus, and nuclei in the brain
stem reticular formation [46]. Additionally, improve-
ments in smooth pursuit with STN stimulation could be
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about by re-activation of dopamine pathways [47]. Atten-
tion is a well-known actor in the control of smooth pur-
suit performance [32,33]. Interestingly, the STN and
globus pallidum have direct connections to the attention
network [47].
Saccadic eye movements and deep brain stimulation
Saccade eye movements were clearly improved by STN
stimulation alone, though mainly their amplitude accur-
acy. These improvements were clearer for smaller sac-
cadic amplitudes (i.e., at 20 and 40 degrees), suggesting
that STN stimulation improves the capacity to perform
controlled small amplitude saccades more than the cap-
acity to perform large amplitude saccades. One previous
study did not detect any effect on saccades when the
STN stimulation was turned ON, but their values were
close to normal already with anti-PD medication and
with the DBS turned OFF [29]. The improved saccadic
performance found with DBS ON in the present study is
in line with other reports [22-24,27]. Given, the vast im-
provements in saccadic performance observed in the
present study as well as others, STN stimulation may re-
establish direct signals involved in saccadic eye move-
ments, such as to the superior colliculus. One strong
possibility is that STN stimulation affects the substantia
nigra reticulate-superior colliculi pathway since the stri-
atum has a major outflow of signals via the substantia
nigra pars reticulata to the superior colliculus [14]. In
line with these findings, previous studies show that in
untreated PD, poor smooth pursuit function triggers
catch-up saccades [42] of small amplitude [48].
The saccade ratio shows that the changes in relation-
ship between peak saccade velocity and saccade ampli-
tude were markedly different in DBS OFF and ON
states. As illustrated in Figure 2, although the peak sac-
cade velocity was maintained fairly high, the saccade
amplitude was strikingly lower with DBS OFF compared
with DBS ON. Activation of DBS partly restored the
peak saccade velocity versus saccade amplitude relation-
ship from 19.9 (DBS OFF) to 16.1 (DBS ON), which can
be compared with 12.8 in healthy subjects [33]. Our
findings confirm previous observations by Rascol and
colleagues [16] of abnormal relationships between sac-
cade velocity and saccade amplitude in persons with PD.
This study also revealed that STN stimulation can partly
restore a more normal relationship by enhancing the
ability to perform controlled larger saccade amplitudes.
Saccade and smooth pursuit latency
Eye movements have sometimes been found hyper-
reflexive in patients with PD as compared to healthy
controls, possibly due to PD-induced changes in both
the peripheral perceptual processing and in centralexecutive mechanisms involving the BG [49]. Note-
worthy, the average smooth pursuit latency value found
with DBS ON (218 ms) was almost identical to that
found in healthy subjects (221 ms) [33], whereas the la-
tency with DBS OFF was 171 ms. A potential explan-
ation for this could be that STN stimulation might
suppress a hyperactive start of the smooth pursuit eye
movements and thereby allow the visual target to be
captured better at movement onset. However, it is inter-
esting that patients with PD show impaired predictive
smooth pursuit eye movements in the early stage [50],
indicating multi-component dysfunction.
In our participants, STN stimulation also caused a
small, but non-significant, shortening of saccadic laten-
cies from 177 ms with DBS OFF to 156 ms with DBS
ON, which is quite similar to that found in healthy sub-
jects (153 ms) [33]. Similarly, Yugeta and colleagues
found that STN stimulation improved saccade latency of
memory guided and visually guided saccades [27].
Relationship between UPDRS motor scores and
oculomotor findings
The correlation analysis revealed that many of the oculo-
motor parameters were significantly related to the
UPDRS motor scores (i.e. part III) or showed trends of
such relationship. Saccadic latency reduction has previ-
ously been shown to correlate with improvements of
motor symptoms with the STN stimulation turned ON
[26]. This was however not shown in the study by
Pinkhardt and colleagues [29] possibly because of the
continued use of anti-PD medications. Lohnes and Ear-
hart evaluated the effects of STN stimulation alone, and
their UPDRS III scores correlated with the percentage
improvement in saccade amplitude, but not with saccade
velocity [24]. Baseline postural instability and gait scores
of the UPDRS part III did however correlate with im-
provements in both saccade amplitude and velocity.
Their findings may indicate that oculomotor perform-
ance in people with PD relates more to gait and balance
problems than motor symptoms per se (i.e. as assessed
by the UPDRS part III). This further highlights the im-
portance of taking oculomotor performance into account
while simultaneously investigating balance problems in PD.
In the present study, the statistical relationships found
between smooth pursuit and saccade performance and
the UPDRS motor scores were only present with DBS
ON. To speculate, one factor that could substantially in-
fluence many scores assessed by UPDRS in DBS OFF
state, without influencing oculomotor performance, is
tremor. Notably, many subjects had clear tremor with
DBS OFF but the STN stimulation almost completely
eliminated this symptom in DBS ON in nearly all sub-
jects assessed. Hence, the UPDRS scores may not always
properly reflect the oculomotor functions in certain
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OFF and without PD medication. This observation sug-
gests that important functions, such as oculomotor per-
formance, might have to be assessed separately in each
state to properly provide detailed supplementary infor-
mation to the general UPDRS motor scoring, congruent
to other reports [22,23].
Confounding factors
This study was performed on a limited number of sub-
jects. The main reason for this was the restricted inclusion
criteria applied to avoid interacting and confounding fac-
tors. For example, the subjects investigated were within a
limited age range and were assessed within a limited time
after DBS surgery. Possible confounding or interacting
factors such as time after surgery, age at surgery, sickness
duration and PD medication at the time of investigation
were investigated using correlation analysis. In the mater-
ial investigated, none of these factors were found to have a
systematic influence on oculomotor performance, though
such influences cannot and should not be excluded on
general basis. Hence, this study was conducted on a well-
defined group to ensure that the effects observed were
most likely from STN stimulation alone. The statistical
evaluation of the assessments revealed consistent effects
among the subjects, evidencing that both saccadic and
smooth pursuit eye movements were significantly im-
proved by STN stimulation in persons with PD.
A factor difficult to account for is whether STN stimula-
tion also influences attention and cognitive functions. The
STN receives projections involved in emotional and cog-
nitive activities from the anterior cingulate, inferior frontal
cortex and medial and dorsolateral pre-frontal cortices
[47], and an integrative function has been suggested [51].
Indeed, recent evidence suggests that DBS stimulation of
the STN may have some involvement in modifying atten-
tional cerebral networks [47]. Noteworthy, attention is
also important for human motor control and for oculo-
motor performance [52,53]. Hence, one cannot rule out
that improvements in attention and cognition partly ac-
count for the improvements recorded in oculomotor per-
formance with STN stimulation. However, given the
revealed relationships between several oculomotor param-
eters and UPDRS motor scores assessed with DBS ON, it
is likely that not only is oculomotor function changed by
any such attention enhancement induced by STN stimula-
tion, but also motor functions assessed by the UPDRS.
Clinical Implications
Properly functioning saccadic and smooth pursuit eye
movements are vital because these functions bring visual
objects or areas of interest into visual focus and keep
moving objects in focus. Through these abilities, vision
provides exteroceptive information that allows us tointeract with a highly dynamic environment and sup-
ports feedforward motor control which helps us to an-
ticipate change [54]. Hence, the improvements gained by
STN stimulation on oculomotor functions are likely to
have positive implications for patients’ ability to perform
tasks that rely on visual motor control and visual feed-
back such as postural control [55] and reduce side-
effects from otherwise present poor oculomotor control
like visual distortions and dizziness.
Currently, many evaluations concerning persons with
PD (e.g., effectiveness of therapeutic interventions includ-
ing DBS and progression of the disease) are based on con-
ventional observer-dependent rating scales such as the
UPDRS. This study illustrates that analysis of oculomotor
functions might provide an additional information source
when evaluating the effects of interventions like STN
stimulation. The largely automatic procedures used when
performing the assessments and analyzing the data en-
sures that the patients can be objectively assessed repeat-
edly using a high resolution evaluation scale.
Methodological considerations
The positive influence of STN stimulation on the ability
to perform accurate saccadic and smooth pursuit eye
movements was most clearly illustrated by the novel
smooth pursuit velocity accuracy analysis and the sac-
cadic ratio parameter, the latter commonly called main
sequence [36,37].
The novel smooth pursuit velocity accuracy parameter
provides information about to what degree a steady
smooth pursuit velocity can be maintained without sup-
portive saccades or velocity inaccuracies beyond a 20%
velocity error limit. As evidenced in two independent
studies [32,33] and the phenomena itself previously de-
scribed in other studies [56,57], one of the first signs of
an affected oculomotor function might be an inability to
maintain steady and accurate control of smooth pursuit
movements within acceptable velocity boundaries over
longer periods of time. Furthermore, Armstrong sug-
gests that this method might prove successful for evalu-
ating PD [58]. In the present study and in previous
studies [11,16,40,41], the traditional smooth pursuit gain
analysis also provided significant statistical evidence for
an altered smooth pursuit function, but not with the
same high statistical sensitivity as the velocity accuracy
parameter. Hence, analysis of smooth pursuit velocity
accuracy may provide better means to detect oculo-
motor deficits at an earlier stage in a number of disor-
ders and in persons with PD where other functional
parameters may not.
The saccade ratio parameter illustrates whether there
is an imbalance between saccade velocity and the sac-
cade amplitude. Previous reports have shown a relatively
fixed relationship between the saccade amplitude and
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However, above these saccade amplitudes the relation-
ship changes in a non-linear manner [32,36,37]. Recent
reports have shown that this relationship can be changed
by various factors with central effects such as alcohol in-
toxication and sleep deprivation [32,33]. Such saccade
relationship changes between saccade velocity and the
saccade amplitude were also detected in persons with
PD when using the saccade ratio parameter to assess the
effects of DBS in the STN.
The possible relationship between UPDRS scores and
oculomotor findings were investigated by performing
correlations to each of the oculomotor parameters. One
should be aware of that multiple analyses can increase
the risk of statistical Type 1 errors but also that the
Bonferroni correcting factor under some conditions
could increase the risk of making Type II errors [59].
Specifically, it is difficult to present multiple systematic
relationships in the p-value range of <0.05 to >0.01 with-
out all of them being down-ranked to insignificant level
by Bonferroni. Contradictory, if publishing one finding
at a time, as singled-out observations, then they are in-
dividually regarded as significant evidence for the hy-
pothesis. Moreover, as described by Perneger [59], if
Bonferroni was applied in clinical practice the effects
would be absurd. Hence, it is important that systematic
investigations can be published, i.e., both significant and
insignificant findings, because both kinds of findings are
often of direct clinical relevance. Accordingly, we
present the complete statistical correlation analysis of all
oculomotor parameters so the systematic patterns are
displayed, though we do so with a reminder of being
aware of the problems associated with Type I and Type
II errors.
Conclusions
STN stimulation from DBS alone significantly improves
smooth pursuit and saccade performance in patients
with PD. The improved oculomotor functions with DBS
in the STN may have positive implications for patients’
ability to perform tasks that rely on visual motor control
and visual feedback (such as postural control) and re-
duce side-effects from poor visual control like visual dis-
tortions and dizziness. The findings further indicate a
critical but complex role of the basal ganglia and STN
on oculomotor functions. Moreover, the new oculo-
motor analysis methods used provide a sensitive vehicle
to detect functional enhancements produced by STN
stimulation from DBS alone. These methods could be
useful in detecting subtle pathological changes from PD.
The largely automatic procedures used when performing
the assessments and analyzing the data ensures that the
patients can be objectively assessed repeatedly using a
high resolution evaluation scale.Competing interests
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